Publications To Date


    Filter Publications

    PAGE 6 OF 131 | DISPLAYING 76 - 90 OF 1953 RESULTS

    Tigdel T. et. al., Targeted Transcriptional Profiling of Kidney Transplant Biopsies, 10.1016/j.ekir.2018.01.014, Kidney International Reports, Feb 03, 2018

    Schroeder M. et. al., Hypothalamic miR-219 regulates individual metabolic differences in response to diet-induced weight cycling, 10.1016/j.molmet.2018.01.015, Mol. Metabolism, Feb 02, 2018

    Lieberman N.A.P. et. al., An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells, 10.3389/fimmu.2018.00150, Front. Immunol., Feb 02, 2018

    Sampath S. et. al., Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients, 10.18632/oncotarget.24397 , Oncotarget, Feb 02, 2018

    Revino L. et. al., Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation., 10.1172/JCI92812., JCI, Feb 01, 2018

    Shukla N. et. al., Multiplexed Detection and Quantitation of Extracellular Vesicle RNA Expression Using NanoString., 10.1007/978-1-4939-7652-2_14., Methods Mol. Biol., Feb 01, 2018

    Bhagirath D. et. al., MicroRNA-1246 is an exosomal biomarker for aggressive prostate cancer., 10.1158/0008-5472.CAN-17-2069, Can. Res., Feb 01, 2018

    Daemen A. et. al., HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors, 10.1186/s13058-018-0933-y, Breast Can. Res., Jan 30, 2018

    Katsumoto A. et. al., Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model., 10.1186/s12974-018-1075-y., J. Neuroinflamm., Jan 30, 2018

    Kessous R. et. al., Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer., 10.1016/j.ygyno.2018.01.017, Gynecol. Oncol., Jan 29, 2018

    Li Y.Y. et. al., SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis., 10.1111/cas.13515, Cancer Sci., Jan 25, 2018

    Laenkholm A.V. et. al., PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer., 10.1200/JCO.2017.74.6586. , J. Clin. Oncol., Jan 25, 2018

    Ricca J.M. et. al., Pre-existing immunity to oncolytic virus potentiates its immunotherapeutic efficacy., 10.1016/j.ymthe.2018.01.019, Mol. Therapy, Jan 25, 2018

    Ferguson S.W. et. al., The microRNA regulatory landscape of MSC-derived exosomes: a systems view, 10.1038/s41598-018-19581-x, Sci. Reports, Jan 23, 2018

    Van Laar R. et. al., Development and validation of a plasma-based melanoma biomarker suitable for clinical use, 10.1038/bjc.2017.477, Br. J. Cancer, Jan 23, 2018